Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,089
Total Claims
$749K
Drug Cost
1,743
Beneficiaries
$430
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 2,621 Pain Management providers
+63%
Opioid rate vs peers
67.2% vs 41.3% avg
+8%
Cost per patient vs peers
$430 vs $399 avg
+103%
Brand preference vs peers
7.6% vs 3.8% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
67.2%
Opioid Rate
5,438
Opioid Claims
$602K
Opioid Cost
23.0%
Long-Acting Rate
This provider's opioid prescribing rate of 67.2% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 615 claims · $327K
Generic: 7,474 claims · $422K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Hcl/Acetaminophen | 20 | $99K |
| Buprenorphine | 305 | $79K |
| Hydrocodone/Acetaminophen | 2,155 | $69K |
| Oxycodone Hcl | 101 | $69K |
| Oxycodone Myristate | 71 | $54K |
| Buprenorphine Hcl | 71 | $44K |
| Tapentadol Hcl | 32 | $34K |
| Oxycodone Hcl/Acetaminophen | 690 | $23K |
| Tapentadol Hcl | 16 | $23K |
| Oxymorphone Hcl | 28 | $20K |
| Oxycodone Hcl | 675 | $19K |
| Pregabalin | 497 | $18K |
| Fentanyl | 99 | $13K |
| Morphine Sulfate | 313 | $10K |
| Pregabalin | 13 | $8,974 |
Prescribing Profile
32
Unique Drugs
21.0
Anomaly Score
Patient Profile
66
Avg Age
66%
Female
1.75
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About